PlumBot: Bot: Creating new article from JSON

2026-03-16T12:32:41Z

Bot: Creating new article from JSON

New page

🏗️ '''Structured product''' in the insurance context refers to a pre-packaged financial instrument — typically combining fixed-income securities, [[Definition:Derivative | derivatives]], and sometimes equity components — that is either held as an [[Definition:Investment portfolio | investment asset]] by an [[Definition:Insurance carrier | insurer]], used to back [[Definition:Insurance liability | policyholder obligations]] such as [[Definition:Variable annuity | variable annuities]] or [[Definition:Unit-linked insurance | unit-linked policies]], or created by insurers and reinsurers as a vehicle to transfer [[Definition:Underwriting risk | underwriting risk]] to the [[Definition:Capital markets | capital markets]]. The term encompasses a wide range of instruments, from [[Definition:Collateralized debt obligation (CDO) | collateralized debt obligations]] and [[Definition:Mortgage-backed security (MBS) | mortgage-backed securities]] held in insurer general accounts, to [[Definition:Insurance-linked security (ILS) | insurance-linked securities]] such as [[Definition:Catastrophe bond | catastrophe bonds]] that package [[Definition:Catastrophe risk | catastrophe risk]] into tradable notes, to index-linked savings products sold to retail [[Definition:Policyholder | policyholders]]. Their defining characteristic is the tailored combination of payoff profiles — engineered to meet specific risk-return, duration-matching, or risk-transfer objectives that plain-vanilla instruments cannot achieve on their own.

⚙️ On the investment side, insurers are significant buyers of structured products because their complex [[Definition:Cash flow | cash flow]] profiles can be matched to the duration and yield requirements of long-tail [[Definition:Life insurance | life]] and [[Definition:Annuity | annuity]] liabilities. A [[Definition:Collateralized loan obligation (CLO) | CLO]] tranche rated investment grade, for example, may offer a spread premium over comparably rated corporate bonds while fitting within regulatory investment limits. However, the embedded complexity carries risks that regulators monitor closely: under [[Definition:Solvency II | Solvency II]], insurers must apply a [[Definition:Look-through approach | look-through approach]] to structured holdings, assessing the underlying asset exposures for [[Definition:Capital charge | capital charge]] purposes rather than treating the wrapper at face value. The [[Definition:National Association of Insurance Commissioners (NAIC) | NAIC]] in the United States has similarly tightened scrutiny of structured securities held by insurers, particularly [[Definition:Private credit | private credit]] structures originated through affiliated asset managers, introducing modeled [[Definition:Risk-based capital (RBC) | risk-based capital]] charges that reflect actual loss distributions rather than relying solely on rating agency designations. On the risk-transfer side, the creation of structured products like [[Definition:Catastrophe bond | catastrophe bonds]] involves establishing a [[Definition:Special purpose vehicle (SPV) | special purpose vehicle]] that issues notes to investors and uses the proceeds as [[Definition:Collateral | collateral]] against specified insurance loss triggers — a mechanism that allows [[Definition:Reinsurance | reinsurers]] and primary insurers to access capital market capacity beyond the traditional reinsurance market.

💡 The intersection of structured products and insurance has been shaped by hard lessons. The 2008 financial crisis exposed the dangers of insurers holding concentrated positions in opaque structured credit instruments — most notably at [[Definition:AIG | AIG]], whose Financial Products unit wrote [[Definition:Credit default swap (CDS) | credit default swaps]] on structured mortgage portfolios, ultimately triggering one of the largest government bailouts in history. That episode led to fundamental reforms in how regulators evaluate insurer exposures to structured products, including enhanced [[Definition:Stress testing | stress testing]], stricter [[Definition:Asset valuation reserve | asset valuation]] standards, and greater transparency requirements. Today, structured products remain integral to insurance investment strategies and risk management, but under far more rigorous oversight. For [[Definition:Insurtech | insurtech]] platforms and [[Definition:Asset management | asset managers]] serving the insurance sector, the ability to model, report, and monitor structured product exposures — accounting for look-through requirements, [[Definition:Spread risk | spread risk]] charges, and concentration limits across different regulatory regimes — represents a critical capability. Meanwhile, the ILS market continues to grow as a structured mechanism for efficiently channeling investor capital toward peak [[Definition:Natural catastrophe | natural catastrophe]] risks, demonstrating the enduring utility of well-designed structured products when transparency and governance are maintained.

'''Related concepts:'''
{{Div col|colwidth=20em}}
* [[Definition:Insurance-linked security (ILS)]]
* [[Definition:Catastrophe bond]]
* [[Definition:Collateralized debt obligation (CDO)]]
* [[Definition:Look-through approach]]
* [[Definition:Special purpose vehicle (SPV)]]
* [[Definition:Spread risk]]
{{Div col end}}

Definition:Structured product - Revision history

PlumBot: Bot: Creating new article from JSON